Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Chemicals Industry Analysis

UpdatedJul 01, 2026
DataAggregated Company Financials
Companies5
  • 7D2.6%
  • 3M21.1%
  • 1Y-11.5%
  • YTD9.8%

Over the last 7 days, the Chemicals industry has risen 1.3%, driven by gains from Givaudan of 4.3%. In contrast, the industry has lost 12% in the last 12 months. Earnings are forecast to grow by 8.3% annually.

Industry Valuation and Performance

Has the Swiss Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 Jul 2026CHF 77.0bCHF 24.9bCHF 2.4b29.5x31.5x3.1x
Fri, 29 May 2026CHF 70.8bCHF 24.9bCHF 2.4b25.2x28.9x2.8x
Sun, 26 Apr 2026CHF 67.7bCHF 24.9bCHF 2.4b24.2x27.7x2.7x
Tue, 24 Mar 2026CHF 61.8bCHF 24.9bCHF 2.4b22.9x25.3x2.5x
Thu, 19 Feb 2026CHF 69.6bCHF 25.3bCHF 2.7b24.8x25.3x2.8x
Sat, 17 Jan 2026CHF 70.3bCHF 25.4bCHF 2.8b23.9x25.4x2.8x
Mon, 15 Dec 2025CHF 69.3bCHF 25.4bCHF 2.8b23.7x25x2.7x
Wed, 12 Nov 2025CHF 72.2bCHF 25.4bCHF 2.8b24.7x26.1x2.8x
Fri, 10 Oct 2025CHF 74.5bCHF 25.6bCHF 2.8b25.6x26.6x2.9x
Sun, 07 Sep 2025CHF 79.1bCHF 25.6bCHF 2.8b26.9x28.3x3.1x
Tue, 05 Aug 2025CHF 79.8bCHF 25.7bCHF 2.9b26.9x27.9x3.1x
Thu, 03 Jul 2025CHF 87.8bCHF 25.8bCHF 3.0b29.8x29.1x3.4x
Sat, 31 May 2025CHF 91.1bCHF 25.8bCHF 3.0b30x30.2x3.5x
Mon, 28 Apr 2025CHF 85.7bCHF 25.8bCHF 3.0b28.4x28.5x3.3x
Wed, 26 Mar 2025CHF 89.4bCHF 25.8bCHF 3.0b30x29.6x3.5x
Fri, 21 Feb 2025CHF 92.3bCHF 25.8bCHF 2.9b32x31.6x3.6x
Sun, 19 Jan 2025CHF 90.5bCHF 25.5bCHF 2.9b32x31.6x3.5x
Tue, 17 Dec 2024CHF 91.5bCHF 25.5bCHF 2.9b31.4x32x3.6x
Thu, 14 Nov 2024CHF 92.1bCHF 25.5bCHF 2.9b32.5x32.2x3.6x
Sat, 12 Oct 2024CHF 102.2bCHF 25.6bCHF 2.8b35.2x36x4x
Mon, 09 Sep 2024CHF 102.5bCHF 25.6bCHF 2.8b34.7x36x4x
Wed, 07 Aug 2024CHF 96.5bCHF 25.7bCHF 2.8b33.5x34x3.8x
Fri, 05 Jul 2024CHF 104.3bCHF 25.2bCHF 2.6b38.3x40.3x4.1x
Sun, 02 Jun 2024CHF 105.3bCHF 25.2bCHF 2.6b38x40.7x4.2x
Tue, 30 Apr 2024CHF 100.7bCHF 25.2bCHF 2.6b38.3x38.9x4x
Thu, 28 Mar 2024CHF 100.3bCHF 25.2bCHF 2.5b40.3x40.2x4x
Sat, 24 Feb 2024CHF 95.4bCHF 25.8bCHF 2.2b39.1x42.9x3.7x
Mon, 22 Jan 2024CHF 90.0bCHF 26.1bCHF 2.3b34.7x39.8x3.4x
Wed, 20 Dec 2023CHF 99.4bCHF 26.1bCHF 2.3b37.4x43.9x3.8x
Fri, 17 Nov 2023CHF 90.5bCHF 26.1bCHF 2.3b33.8x40x3.5x
Sun, 15 Oct 2023CHF 86.6bCHF 25.7bCHF 2.2b32.1x38.9x3.4x
Tue, 12 Sep 2023CHF 87.6bCHF 25.7bCHF 2.2b33x39.3x3.4x
Thu, 10 Aug 2023CHF 92.0bCHF 25.7bCHF 2.5b35.2x36.6x3.6x
Sat, 08 Jul 2023CHF 88.4bCHF 26.1bCHF 2.5b32.4x35.8x3.4x
Price to Earnings Ratio

35.8x


Total Market Cap: CHF 88.4bTotal Earnings: CHF 2.5bTotal Revenue: CHF 26.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Chemicals Industry Price to Earnings3Y Average 33.1x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swiss Chemicals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 33.1x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Chemicals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the Swiss Materials industry?

CH Market1.83%
Materials0.35%
Chemicals2.56%
Specialty Chemicals2.56%
Industry PE
  • Investors are most optimistic about the Specialty Chemicals industry, which is trading close to its 3-year average PE ratio of 33.1x.
    • Analysts are expecting annual earnings growth of 8.3%, which is higher than its past year's earnings decline of 1.7% per year.
  • Investors are most pessimistic about the Specialty Chemicals industry, which is trading close to its 3-year average of 33.1x.
Forecasted Growth
  • Analysts are most optimistic on the Specialty Chemicals industry, expecting annual earnings growth of 8.3% over the next 5 years.
  • This is better than its past earnings decline of 1.7% per year.
  • In contrast, the Specialty Chemicals industry is expected to see its earnings grow by 8.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GIVN GivaudanCHF 3.42k4.3%
+CHF 1.3b		-11.8%PE29.5x
SIKA SikaCHF 166.753.5%
+CHF 914.5m		-22.1%PE25.6x
GURN Gurit HoldingCHF 41.4023.2%
+CHF 36.4m		146.4%PS0.6x

Latest News

GURN
CHF 41.40
Gurit Holding
7D
23.2%
1Y
146.4%
New Narrative • Jun 26

Wind And Subsea Demand Will Drive A Stronger Future For This Composite Supplier

Catalysts About Gurit Holding Gurit Holding supplies advanced composite materials, kits and tooling for wind energy, marine and industrial applications. What are the underlying business or industry changes driving this perspective?
GIVN
CHF 3,420.00
Givaudan
7D
4.3%
1Y
-11.8%
Narrative Update • Jun 25

GIVN: Pricing Power And AI Beauty Push Will Shape Future Margin Resilience

Givaudan's analyst fair value estimate has been adjusted modestly higher to CHF 3,468 from CHF 3,415, reflecting analysts' updated assumptions for slightly stronger revenue growth, a similar discount rate, a broadly unchanged profit margin profile, and a small increase in expected future P/E multiples, alongside a recent series of price target revisions across the Street that now cluster in the CHF 2,900 to CHF 3,500 range. Analyst Commentary Recent research on Givaudan points to a mixed but generally constructive view, with several firms adjusting price targets in a relatively tight CHF 2,900 to CHF 3,500 band and a blend of rating upgrades and downgrades.
SIKA
CHF 166.75
Sika
7D
3.5%
1Y
-22.1%
Narrative Update • Jun 24

SIKA: New Facilities And Mixed Ratings Set Up Measured Repricing Potential

The analyst price target for Sika has been adjusted slightly higher to CHF 180.69. Analysts point to refined assumptions on margins, a modestly higher future P/E of about 22.73, and recent target moves, such as the JPMorgan upgrade to Neutral with a CHF 165 target, as support for the updated view.
CLN
CHF 7.05
Clariant
7D
-5.1%
1Y
-16.7%
Narrative Update • Jun 23

CLN: Pricing Power And Specialty Focus Will Drive Re Rating Potential

Clariant's analyst price target has been revised lower by CHF 1.40 to reflect a recalibrated fair value, with analysts citing recent cuts to CHF 7.50 from Deutsche Bank and Citi, as well as more balanced views from Goldman Sachs at CHF 8.50 and JPMorgan at CHF 9.30, as they reassess the stock's quality profile, pricing power and valuation. Analyst Commentary Recent research on Clariant points to a mixed but increasingly constructive tone, with several bullish analysts highlighting improving quality perceptions and a more supportive view on valuation.
EMSN
CHF 693.00
EMS-CHEMIE HOLDING
7D
-1.3%
1Y
15.4%